A detailed history of High Tower Advisors, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 303,345 shares of RLAY stock, worth $1.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
303,345
Previous 247,291 22.67%
Holding current value
$1.86 Million
Previous $2.05 Million 3.65%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.9 - $8.02 $330,718 - $449,553
56,054 Added 22.67%
303,345 $1.98 Million
Q1 2024

May 06, 2024

BUY
$7.5 - $12.07 $258,750 - $416,415
34,500 Added 16.21%
247,291 $2.05 Million
Q4 2023

Feb 12, 2024

SELL
$6.01 - $11.48 $436,037 - $832,896
-72,552 Reduced 25.43%
212,791 $2.34 Million
Q3 2023

Nov 08, 2023

BUY
$8.24 - $12.97 $2.35 Million - $3.7 Million
285,343 New
285,343 $2.4 Million
Q2 2022

Aug 10, 2022

BUY
$13.31 - $34.88 $238,794 - $625,782
17,941 New
17,941 $302,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $738M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.